This trial is testing a new cancer drug to see if it is safe and effective.
7 Primary · 16 Secondary · Reporting Duration: Study duration of approximately 36 months
Experimental Treatment
430 Total Participants · 23 Treatment Groups
Primary Treatment: IGM-8444 · No Placebo Group · Phase 1
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Florida | 100.0% |
18 - 65 | 100.0% |
Florida Cancer Specialists | 100.0% |
Met criteria | 100.0% |